A Program for Neuropsychological Investigation of Deep Brain Stimulation (PNIDBS) in movement disorder patients: Development, feasibility, and preliminary data

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 13, Issue 3, 2000, Pages 204-219

  Morrison, Chris E ^a,b   Borod, Joan C ^a,b   Brin, Mitchell F ^a   Raskin, Sarah A ^c   Germano, Isabelle M ^a   Weisz, Donald J ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c TRINITY COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; DEMOGRAPHY; DEPRESSION; DEPTH PERCEPTION; DYSTONIA; ELECTRODE; FEMALE; HUMAN; LANGUAGE; MALE; MEMORY; METHODOLOGY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK FACTOR;

BRAIN; CLINICAL PROTOCOLS; DYSTONIA; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PILOT PROJECTS;

EID: 0033915065     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (145)

1. Andy PJ. Thalamic stimulation for control of movement disorders. Appl Neurophysiol 1983;46:107-11.
2. Benabid AL, Pollak P, Louveau A, et al. Chronic VIM-thalamic stimulation in movement disorders. Curr Probl Neurol 1989;9: 413-5.
3. Goetz CG, DeLong MR, Penn RD, Bakay RAE. Neurosurgical horizons in Parkinson's disease. Neurology 1993;43:1-7.
4. Alesch F, Pinter MM, Helscher RJ, et al. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) 1995;136:75-81.
5. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-9.
6. Kumar R, Lozano AM, Montgomery E, Lang AE. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998;13:73-82.
7. Volkmann J, Sturm V, Weiss P, et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 1998;44:953-61.
8. Broggi G. Chronic deep brain stimulation: clinical results. In: Germane IM, ed. Neurosurgical treatment of movement disorders. Park Ridge, IL: American Association of Neurological Surgeons;1998:169-75.
9. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-6.
10. Limousin P, Pollak P, Hoffmann D, et al. Abnormal involuntary movements induced by subthalamic stimulation in parkinsonian patients. Mov Disord 1996;11:231-5.
11. Pollak P, Benabid AL, Gervason CL, et al. Long-term effects of chronic stimulation of the ventral intermediate thalamic nucleus in different type of tremor. Adv Neurol 1993;60:408-13
12. Jankovic J. Pathophysiology and clinical assessment of motor symptoms in Parkinson's disease. In Koller WC, ed. Handbook of Parkinson's disease. New York: Dekker;1992:129-57.
13. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925-64.
14. Britton TC. Essential tremor and its variants. Curr Opin Neurol 1995;8:314-9.
15. Uitti RJ. Medical treatment of essential tremor and Parkinson's disease. Geriatrics 1998;53:46-57.
16. Benabid AL, Pollak P, Seigneuret E, et al. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 1993;58:39-44.
17. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-14.
18. Hubble JP, Busenbark KL, Wilkinson S, et al. Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Mov Disord 1997;12:337-41.
19. Benabid AL, Pollak P, Gross C, et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 1994;62:76-84.
20. Moro E, Scerrati M, Romito LMA, et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
21. Olanow CW, Germano IM, Brin MF, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease. Mov Disord 1996;11:598-9.
22. Pahwa R, Wilkinson S, Smith D, et al. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 1997;49:249-53.
23. Jankovic J, Fahn S. Dystonic disorders. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams & Wilkins;1993:337-74.
24. Bressman S, de Leon D, Raymond D, et al. Clinical-genetic spectrum of primary dvstonia. In: Fahn S, Marsden CD, DeLong MR, eds. Dystonia 3. Philadelphia: Lippincott-Raven;1998:79-91.
25. Brin MF, Germano I, Danisi FO, et al. Deep brain stimulation (DBS) of pallidum in intractable dystonia. Mov Disord 1998; 13(Suppl 2):S274.
26. Coubes P, Humbertclaude V, Bauchet L, et al. Bilateral chronic electrical stimulation of the internal globus pallidus as a treatment of idiopathic dystonia in musculorum deformans: case report. Stereotact Funct Neurosurg 1996;67:70.
27. Sellal F, Hirsch E, Barth P, et al. A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation. Mov Disord 1993;8:515-8.
28. Germano IM. Chronic deep brain stimulation: indications and techniques. In: Neurosurgical treatment of movement disorders. Park Ridge, IL: American Association of Neurological Surgeons;1998: 159-67.
29. Starr PS, Vitek JL, Bakay RAE. Deep brain stimulation for movement disorders. Neurosurg Clin North Am 1998;9:381-404.
30. Benabid AL, Pollak P, Hoffmann D, et al. Chronic high-frequency thalamic stimulation in Parkinson's disease. In: Koller WC, ed. Therapv of Parkinson's disease. New York: Marcel Dekker 1996: 381-401.
31. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease: two targets? Neurology 1997;49:1564-9.
32. Limousin P, Greene J, Pollak P, et al. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997;42:283-91.
33. Krack P, Pollak P, Limousin P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43: 180-92.
34. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7:2-13.
35. Duff J, Sime E. Surgical interventions in the treatment of Parkinson's disease (PD) and essential tremor (ET): medial pallidotomy in PD and chronic deep brain stimulation (DBS) in PD and ET. Axone 1997;18:85-9.
36. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-7.
37. Pollak P, Benabid AL, Limousin P, et al. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Adv Neurol 1996;69:591-4.
38. Girotti F, Carella F, Pia Grassi M, et al. Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease. J Neurol Neurosurg Psychiatry 1986;49:657-60.
39. Stern Y, Mayeux R, Ilson J, et al. Pergolide therapy for Parkinson's disease: neurobehavioral changes. Neurology 1984;34:201-4.
40. Cotzias GC, Papavasiliou PS, Gellene R. Modifications of parkinsonism - chronic treatment with L-dopa. N Engl J Med 1969;280: 337-45.
41. Brown RG, Marsden CD, Quinn N, Wyke MA. Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984;47:454-65.
42. Gotham AM, Brown RG, Marsden CD. "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 1988;111:299-321.
43. Lange KW, Robbins TW, Marsden CD, et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 1992;107:394-404.
44. Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction. Neurology 1994;44:319-26.
45. Mohr E, Fabbrini G, Ruggier S, et al. Cognitive concomitants of dopamine system stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:1192-6.
46. Berger HJ, van Hoof JJM, Van Spaendonck KPM, et al. Haloperidol and cognitive shifting. Neuropsychologia 1989;27:629-39.
47. Peretti CS, Danion JM, Kauffmann-Muller F, et al. Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers. Psychopharmacology (Berl) 1997;131:329-38.
48. Brin MF. Treatment of dystonia. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. New York: Williams & Wilkins;1998:553-78.
49. Fahn S. Systemic therapy for dystonia. Can J Neurol Sci 1987;14: 528-32.
50. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease. Neurology 1998;50(Suppl 3):S1-57.
51. Reid WGJ, Broe GA, Morris JGL, et al. The role of cholinergic deficiency in neuropsychological deficits in idiopathic Parkinson's disease. Dementia 1992;2:114-20.
52. Stern Y, Mullen L, Fahn S. Long-term effects of high-dose anticholinergic medications. Neurology 1988;38(Suppl 1):S248-9.
53. Taylor AE, Lang AE, Saint-Cyr JA, et al. Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Clin Neuropharmacol 1991; 14:62-77.
54. Van Spaendonck KPM, Berger HJC, Horstink MWI, et al. Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy. Neuropsychologia 1993;31:407-11.
55. Walkup J. Increased anticholinergic levels, memory and judgement. Human Psychopharmacol 1991;6:189-96.
56. Greene P. Medical and surgical therapy of idiopathic torsion dystonia. In: Kurlan R, ed. Treatment of movement disorders. Philadelphia: JB Lippincott;1995:153-81.
57. Dalrymple-Alford JC, Jamieson CF, Donaldson IM. Effects of selegiline (Deprenyl) on cognition in early Parkinson's disease. Clin Neuropharmacol 1995;18:348-59.
58. Kieburtz K, McDermott M, Como P, et al. The effect of Deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurology 1994;44:1756-9.
59. Portin R, Rinne UK. The effects of Deprenyl (selegiline) on cognition and emotion in parkinsonian patients undergoing long-term levodopa treatment. Acta Neurol Scand Suppl 1983;95:135-44.
60. Gasparini M, Fabrizio E, Bonifati V, Meco G. Cognitive improvement during Tolcapone treatment in Parkinson's disease. J Neural Transm 1997;104:887-94.
61. Caparros-Lefebvre D, Blond S, Pecheux N, Petit FPH. Evaluation neuropsychologique avant et apres stimulation thalamique chez 9 parkinsoniens. Rev Neurol (Paris) 1992;148:117-22.
62. Troster AI, Fields JA, Wilkinson SB, Koller WC. Changes in cognitive functions following unilateral thalamic VIM nucleus stimulator implantation for pharmacotherapy-resistant Parkinson's disease: some preliminary observations. Poster session presented at the 25th Annual Meeting of the International Neuropsychological Society. Orlando, FL, February 5, 1997.
63. Troster AI, Fields JA, Wilkinson SB, et al. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology 1997; 49:1078-83.
64. Ardouin C, Pillon B, Peiffer E, et al. Bilateral stimulation of STN or GPi does not affect cognitive functions in Parkinson's disease. Mov Disord 1998;13(Suppl 2):S136-6.
65. Jahanshahi M, Ardouin C, Brown RG, et al. The relative impact of bilateral stimulation of the subthalamic nucleus (STN) or globus pallidus (GPi) on executive function in Parkinson's disease (PD). Mov Disord 1998;13(Suppl 2):S199.
66. Rubio B, Barcia-Salorio JL, Grafman J, Pascual-Leone A. Effect of globus pallidus (GPi) stimulation on the Tower of London and the Stroop Test in Parkinson's disease. Mov Disord 1996;11(Suppl 1):S113.
67. Troster AI, Wilkinson SB, Fields JA, et al. Chronic electrical stimulation of the left ventrointermediate (VIM) thalamic nucleus for the treatment of pharmacotherapy-resistant Parkinson's disease: a differential impact on access to semantic and episodic memory. Brain Cogn 1998;38:125-49.
68. Benedict RHB, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 1998;20:339-52.
69. Randt CT, Brown ER. Randt memory test. Bayport, NY: Life Science Associates, 1984.
70. Cooper JA, Sagar HJ, Jordan N, et al. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2092-122.
71. Portin R, Rinne UK. Neuropsychological responses of parkinsonian patient to long-term levodopa treatment. In: Rinne UK, Klingler M, Stamm G, eds. Parkinson's disease: current progress, problems, and management. New York: Elsevier;1980:271-312.
72. Sharpe MH. Auditory attention in early Parkinson's disease: an impaitment in focused attention. Neuropsychologia 1992;30: 101-6.
73. Stern Y, Mayeux R, Cote L. Reaction time and vigilance in Parkinson's disease. Arch Neurol 1984;41:1086-9.
74. Wright MJ, Burns RJ, Geffen GM, Geffen LB. Covert orientation of visual attention in Parkinson's disease: an impairment in the maintenance of attention. Neuropsychologia 1990;28:151-9.
75. Schretlen D. Brieftest of attention. Odessa, FL: Psychological Assessment Resources, 1989.
76. Beatty WW, Monson N, Goodkin DE. Access to semantic memory in Parkinson's disease and multiple sclerosis. J Geriatr Psychiatry Neurol 1989;2:153-62.
77. Cools AR, Van Den Bercken JHL, Horstink MWI, et al. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984;47:443-53.
78. Matison R, Mayeux R, Rosen J, Fahn S. "Tip of the tongue" phenomenon in Parkinson's disease. Neurology 1982;32:567-70.
79. Raskin SA, Sliwinski M, Borod JC. Clustering strategies on tasks of verbal fluency in Parkinson's disease. Neuropsychologia 1992; 30:95-9.
80. Darley FL, Brown JR, Swenson WM. Language changes after neurosurgery for parkinsonism. Brain Lang 1975;2:65-9.
81. Vilkki J, Laitinen LV. Effects of pulvinotomy and ventrolateral thalamotomy on some cognitive functions. Neuropsychologia 1976;14:67-78.
82. Lang AE, Lozano A, Tasker R, et al. Neuropsychological and behavioral changes and weight gain after medial pallidotomy. Ann Neurol 1997;41:834-6.
83. Masterman DL, Bronstein J, DeSalles AP, et al. Cognitive and behavioral performance following unilateral ventroposterior pallidotomy. Neurology 1997;48:A252-3 (abstract).
84. Benton A, Hamsher K. Multilingual aphasia examination. Manual. Iowa City, IA: AJA Associates, 1978.
85. Kaplan E, Goodglass H, Weintraub S. The Boston naming test. Boston: E. Kaplan & H. Goodglass, 1978.
86. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer's disease. J Gerontol Psychol Sci 1992;47:154-8.
87. Venneri A, Nichelli P, Modenesi G, et al. Impairment in dating and retrieving remote events in patients with early Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:410-3.
88. Raskin SA, Borod JC, Wasserstein J, et al. Visuospatial orientation in Parkinson's disease. Int J Neurosci 1990;51:9-18.
89. Sahakian BJ, Morris RG, Evenden JL, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988;111:695-718.
90. Tang C, Liu Y. Impairment of visual form discrimination in Parkinson's disease. Acta Psychol Sinica 1993;25:258-63.
91. Benton A, Hamsher K, Varney N, Spreen O. Contributions to neuropsychological assessment. New York: Oxford University Press, 1983.
92. Boller F, Passafiume D, Keefe NC, et al. Visuospatial impairment in Parkinson's disease. Arch Neurol 1984;41:485-90.
93. Bowen FP, Burns MM, Brady EM, Yahr MD. A note on alterations of personal orientation in parkinsonism. Neurosychologia 1976; 14:425-9.
94. Bowen FP, Hoehn MM, Yahr MD. Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychologia 1972;10:355-61.
95. Hovestadt A, de Jong GJ, Meerwaldt JD. Spatial disorientation as an early symptom of Parkinson's disease. Neurology 1987;37: 485-7.
96. Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991;41:365-9.
97. Natsopoulos D, Bostantzopoulou M-S, Katsarou Z, et al. Space deficits in Parkinson's disease patients: quantitative or qualitative differences from normal controls. Behav Neurol 1993;6:193-206.
98. Money J. Standardized test of direction sense. San Rafael, CA: Academic Therapy Publications, 1976.
99. Woodard JL, Benedict RHB, Roberts VJ, et al. Short-form alternatives to the Judgment of Line Orientation Test. J Clin Exp Neuropsychol 1996;18:898-904.
100. Hooper HE. Hooper visual organization test (VOT). Los Angeles: Western Psychological Services, 1983.
101. Benton AL. A visual retention test for clinical use. New York: The Psychological Corporation, 1945.
102. El-Awar M, Becker JT, Hammond KM, et al. Learning deficit in Parkinson's disease. Arch Neurol 1987;44:180-4.
103. Owen AM, Beksinska M, James M, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993;31:627-44.
104. Taylor AR, Saint-Cyr JA, Lang AE. Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome." Brain Cogn 1990;13:211-32.
105. Tweedy JR, Langer KG, McDowell FH. The effect of semantic relations on the memory deficit associated with Parkinson's disease. J Clin Neuropsychol 1982;4:235-47.
106. Cooper JA, Sagar HJ, Sullivan EV. Short-term mermory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Neuropsychologia 1993;31:933-49.
107. Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning text. San Antonio, TX: Harcourt Brace & Company, 1983.
108. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychologist 1991;5:125-42.
109. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test-Revised: normative data and analysis of interform and test-retest reliability. Clin Neuropsychologist 1998;12: 43-55.
110. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1983.
111. Wechsler D. Wechsler memory scale-revised. San Antonio, TX: The Psychological Corporation, 1987.
112. Downes JJ, Roberts AC, Sahakian BJ, et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989;27:1329-13.
113. Fimm B, Bartl G, Zimmermann P, Wallesch C-W. Different mechanisms underlie shifting set on external and internal cues in Parkinson's disease. Brain Cogn 1994;25:287-304.
114. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115: 1727-51.
115. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease. Brain 1986;109:845-83.
116. VanSpaendonck KPM, Berger HJC, Horstink MWIM, et al. Executive functions and disease characteristics in Parkinson's disease. Neuropsychologia 1990;34:617-26.
117. Flowers KA, Robertson C. The effect of Parkinson's disease on the ability to maintain mental set. J Neurol Neurosurg Psychiatry 1985;48:517-29.
118. Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol 1948;39:15-22.
119. Brown RG, Marsden CD. An investigation of the phenomenon of "set" in Parkinson's disease. Mov Disord 1988;3:152-61.
120. Caltagirone C, Carlesimo A, Nocentini U, Vicari S. Detective concept formation in parkinsonians is independent from mental deterioration. J Neurol Neurosurg Psychiatry 1989;52:334-7.
121. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983;106:257-70.
122. Hsieh S, Lee CY, Tai CT. Set-shifting aptitude in Parkinson's disease: external vs internal cues. Psychol Rep 1995;77:339-49.
123. Richards M, Cote LJ, Stem Y. Executive function in Parkinson's disease: set-shifting or set-maintenance. J Clin Exp Neuropsychol 1993;15:260-79.
124. Downes JJ, Sharp HM, Costall BM, et al. Alternating fluency in Parkinson's disease. Brain 1993;116:887-902.
125. McDonald C, Brown CC, Gorell JM. Impaired set-shifting in Parkinson's disease: new evidence from a lexical decision task. J Clin Exp Neuropsychol 1996;18:793-809.
126. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-62.
127. Newcombe F. Missile wounds to the brain. London: Oxford University Press, 1969.
128. Raskin SA, Borod JC, Tweedy JR. Set-shifting and spatial orientation in patients with Parkinson's disease. J Clin Exp Neuropsychol 1992;14:801-21.
129. Gurd JM, Ward CD, Hodges J. Parkinson's disease and the frontal hypothesis: task alternation in verbal fluency. Adv Neurol 1990; 53:321-5.
130. Dooneief G, Mirabello E, Bell K, et al. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992;49:305-7.
131. Whurr R, Lorch M, Lindsay M, et al. Psychological function in spasmodic dysphonia before and after treatment with botulinum toxin. Journal of Medical Speech Language Pathology 1998;6:81-91.
132. Jahanshahi M, Marsden CD. Depression in torticollis: a controlled study. Psychol Med 1988;18:925-33.
133. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
134. Raskin SA, Borod JB, Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychol Rev 1990;1:185-221.
135. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.
136. Burke RE, Fahn S, Marsden CD, et al. Validity and reliability of a rating scale for the primary dystonias. Neurology 1985;35:73-7.
137. Mattis S. Dementia rating scale: professional manual. Odessa, FL: Psychological Assessment Resources, 1988.
138. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychologist 1989;3:129-36.
139. Vingerhoets G, van der Linden C, Lannoo E, et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:297-304.
140. Karzmark P, Hall K, Englander J. Late-onset postconcussion symptoms after mild head injury: the role of premorbid, injury related, environmental and personality factors. Brain Inj 1995;9: 21-6.
141. Raskin S, Mateer C, Tweeten R. Neuropsychological assessment of mild traumatic brain injury. Clin Neuropsychologist 1998;12:21-30.
142. Stuss DT, Benson DF. Neuropsychological studies of the frontal lobes. Psychol Bull 1984;95:3-28.
143. Caine ED. The neuropsychology of depression: the pseudodementia syndrome. In: Grant I, Adams KM, eds. Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press;1986:221-43.
144. Goodglass H, Kaplan E. Boston diagnostic aphasia exam. Philadelphia: Lea & Febiger, 1983.
145. Hollingshead A. Four-factor index of social status. Unpublished manuscript. Yale University, New Haven, CT, 1977.